Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer Leading to the Inception of “Master Protocols” in Lung Cancer

On February 2, 2012, the National Cancer Institute (NCI) sponsored a 2-day workshop with the NCI Thoracic Malignancies Steering Committee and the Food and Drug Administration to bring together leading academicians, clinicians, industry and government representatives to identify challenges and potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Shakun M., Pazdur, Richard, Abrams, Jeffrey S., Socinski, Mark A., Sause, William T., Harpole, David H., Welch, John J., Korn, Edward L., Ullmann, Claudio Dansky, Hirsch, Fred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165474/
https://www.ncbi.nlm.nih.gov/pubmed/25521397
http://dx.doi.org/10.1097/JTO.0000000000000314

Ejemplares similares

Ejemplares similares